Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.
about
All's well that transcribes well: non-coding RNAs and post-stroke brain damageBrain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.Non-Coding RNAs in Stroke and NeuroprotectionImproved thrombolytic effect with focused ultrasound and neuroprotective agent against acute carotid artery thrombosis in rat.microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model.MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest?miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6.Association Between Single-Nucleotide Polymorphism (SNP) in miR-146a, miR-196a2, and miR-499 and Risk of Ischemic Stroke: A Meta-AnalysisLDL suppresses angiogenesis through disruption of the HIF pathway via NF-κB inhibition which is reversed by the proteasome inhibitor BSc2118.Neuroprotective Effect of Paeonol Mediates Anti-Inflammation via Suppressing Toll-Like Receptor 2 and Toll-Like Receptor 4 Signaling Pathways in Cerebral Ischemia-Reperfusion Injured Rats.TLR2 and TLR4 in the brain injury caused by cerebral ischemia and reperfusion.Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic review.Neuroprotection by astrocytes in brain ischemia: importance of microRNAs.The Emerging Role of Epigenetics in Cerebral Ischemia.Non-coding RNAs and neuroprotection after acute CNS injuries.The role of microRNA in neuronal inflammation and survival in the post ischemic brain: a review.Potential medications or compounds acting on toll-like receptors in cerebral ischemia.MicroRNA-146a Promotes Oligodendrogenesis in Stroke.MicroRNA-146a Mimics Reduce the Peripheral Neuropathy in Type 2 Diabetic Mice.Role of pattern recognition receptors of the neurovascular unit in inflamm-aging.Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity.Epigenetic regulation of inflammation in stroke.
P2860
Q27012757-B5928E42-9E65-4D17-AC4F-B9D247033BE2Q27321637-72CC5C7C-A939-4114-94B0-BC760A97D6C4Q28082190-CE3863BA-5276-4DEA-B74D-F1771C1C83FDQ30356179-93881D50-4313-4630-8662-ECA0B234D522Q34792605-DD18254A-BCA9-4446-A86B-A6D54F3A9741Q35071551-FBEBFEB4-7676-43FD-9D68-819B63D4DE86Q35200037-E6A4B76A-E26B-4583-9FE5-8A6F1F27A6A8Q36336428-2C6DB798-0C5E-4E62-99E2-BF65AD89A0B9Q36557556-3A8339E1-537B-40A7-9CCD-311A093BF0A5Q37560229-91465650-F6F6-4EAB-8F4D-B58C801D067DQ38122360-ADB4C24D-FC9F-48C7-81BC-1103CD85E835Q38148590-29C5380B-A93D-4922-B79A-BF5BBBF2B304Q38165634-EB7B4076-DA02-48AB-9D29-3DF95A08DF82Q38740709-A34425A2-3F7F-42A7-90A5-6A21C6A05AA3Q39107969-A6A7940C-1F47-4919-9AB3-7DAF480A3F0BQ39334671-70BC4C2F-B8F1-47CB-9F52-294EFE3F6A2DQ39344487-647215C5-63C3-4BF6-B063-6E7BB4FEB751Q40135764-20FD3E96-2949-4EC3-94B3-B2444AEAB5CAQ47814946-E554DD64-AC4B-4D1C-AB60-48CF19F1C42EQ47962378-228BEEBE-3FEA-4876-A1E7-9B4204DD1F7AQ54146174-853C896E-A432-4D10-B861-094230DBA76DQ55209717-AF7C3624-D4BE-4D10-A1EE-AB807269019F
P2860
Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Combination therapy with VELCA ...... ke receptor signaling pathway.
@ast
Combination therapy with VELCA ...... ke receptor signaling pathway.
@en
Combination therapy with VELCA ...... ke receptor signaling pathway.
@nl
type
label
Combination therapy with VELCA ...... ke receptor signaling pathway.
@ast
Combination therapy with VELCA ...... ke receptor signaling pathway.
@en
Combination therapy with VELCA ...... ke receptor signaling pathway.
@nl
prefLabel
Combination therapy with VELCA ...... ke receptor signaling pathway.
@ast
Combination therapy with VELCA ...... ke receptor signaling pathway.
@en
Combination therapy with VELCA ...... ke receptor signaling pathway.
@nl
P2093
P2860
P1476
Combination therapy with VELCA ...... ke receptor signaling pathway.
@en
P2093
Haifa Kassis
Xianshuang Liu
Zheng Gang Zhang
P2860
P304
P356
10.1161/ATVBAHA.112.252619
P407
P577
2012-06-21T00:00:00Z